摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(E)-(4R,7S,10R)-4,7-Bis-methoxymethoxy-10-methyl-3,4,7,8,9,10-hexahydro-oxecin-2-one | 264889-51-2

中文名称
——
中文别名
——
英文名称
(E)-(4R,7S,10R)-4,7-Bis-methoxymethoxy-10-methyl-3,4,7,8,9,10-hexahydro-oxecin-2-one
英文别名
(2R,5S,6E,8R)-5,8-bis(methoxymethoxy)-2-methyl-2,3,4,5,8,9-hexahydrooxecin-10-one
(E)-(4R,7S,10R)-4,7-Bis-methoxymethoxy-10-methyl-3,4,7,8,9,10-hexahydro-oxecin-2-one化学式
CAS
264889-51-2
化学式
C14H24O6
mdl
——
分子量
288.341
InChiKey
JUPDKBAVSPSDOH-LQVFNYONSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.1
  • 重原子数:
    20
  • 可旋转键数:
    6
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.79
  • 拓扑面积:
    63.2
  • 氢给体数:
    0
  • 氢受体数:
    6

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    (E)-(4R,7S,10R)-4,7-Bis-methoxymethoxy-10-methyl-3,4,7,8,9,10-hexahydro-oxecin-2-one吡啶对甲苯磺酸 作用下, 以 正丁醇 为溶剂, 反应 2.5h, 以74%的产率得到(-)-decarestrictine C2
    参考文献:
    名称:
    Total synthesis of (–)-(3R,6S,9R)-decarestrictine C2
    摘要:
    Enantioselective synthesis of the proposed structure of (-)-(3R,6S,9R)-decarestrictine C-2 (4) has been accomplished using (2S,5S)-1,2,5,6-hexanetetrol (9) as a C-2-symmetric chiral synthon, in which the diastereoselective aldol-type reaction of a tin(II) enolate of 3-acetyl-4(S)-isopropyl-1,3-thiazolidine-2-thione with the alpha,beta-unsaturated aldehyde was used as a key step. (C) 2000 Elsevier Science Ltd. All rights reserved.
    DOI:
    10.1016/s0040-4039(99)02138-3
  • 作为产物:
    描述:
    Toluene-4-sulfonic acid (2S,5S)-2,5,6-trihydroxy-hexyl ester 在 N-乙基哌啶吡啶咪唑4-二甲氨基吡啶 、 lithium aluminium tetrahydride 、 tin(II) trifluoromethanesulfonate 、 草酰氯 、 Amberlyst A-26 (F(1-)) 、 2,4,6-三氯苯甲酰氯二甲基亚砜三乙胺N,N-二异丙基乙胺 、 zinc(II) chloride 作用下, 以 四氢呋喃二氯甲烷甲苯乙腈 为溶剂, 反应 2.0h, 生成 (E)-(4R,7S,10R)-4,7-Bis-methoxymethoxy-10-methyl-3,4,7,8,9,10-hexahydro-oxecin-2-one
    参考文献:
    名称:
    Total synthesis of (–)-(3R,6S,9R)-decarestrictine C2
    摘要:
    Enantioselective synthesis of the proposed structure of (-)-(3R,6S,9R)-decarestrictine C-2 (4) has been accomplished using (2S,5S)-1,2,5,6-hexanetetrol (9) as a C-2-symmetric chiral synthon, in which the diastereoselective aldol-type reaction of a tin(II) enolate of 3-acetyl-4(S)-isopropyl-1,3-thiazolidine-2-thione with the alpha,beta-unsaturated aldehyde was used as a key step. (C) 2000 Elsevier Science Ltd. All rights reserved.
    DOI:
    10.1016/s0040-4039(99)02138-3
点击查看最新优质反应信息

文献信息

  • Total synthesis of (–)-(3R,6S,9R)-decarestrictine C2
    作者:Mayumi Arai、Nobuyasu Morita、Sakae Aoyagi、Chihiro Kibayashi
    DOI:10.1016/s0040-4039(99)02138-3
    日期:2000.2
    Enantioselective synthesis of the proposed structure of (-)-(3R,6S,9R)-decarestrictine C-2 (4) has been accomplished using (2S,5S)-1,2,5,6-hexanetetrol (9) as a C-2-symmetric chiral synthon, in which the diastereoselective aldol-type reaction of a tin(II) enolate of 3-acetyl-4(S)-isopropyl-1,3-thiazolidine-2-thione with the alpha,beta-unsaturated aldehyde was used as a key step. (C) 2000 Elsevier Science Ltd. All rights reserved.
查看更多

同类化合物

胰岛素原(cattle),29-[N6-[[2-(甲磺酰)乙氧基]羰基]-L-赖氨酸]-59-[N6-[[2-(甲磺酰)乙氧基]羰基]-L-赖氨酸]-(9CI) 十氢-2,7-苯并二氧杂环癸烷-3,6-二酮 二环<3.3.0>-2-氧杂-5-(2-丙烯基)-1-辛烯 乙烯邻苯二甲酸酯 [(E,1R)-1-[(2R,4Z,7S,8R)-7-溴-8-乙基-3,6,7,8-四氢-2H-氧杂环辛三烯-2-基]己-3-烯-5-炔基]乙酸酯 [(2R,3S,4E,6R,7S)-6,7-二羟基-2-甲基-10-氧代-2,3,6,7,8,9-六氢氧杂环辛三烯-3-基] (E)-丁-2-烯酸酯 6,7-二氢-5aH-氧杂环丁烷并[3,2-d][1,3]苯并二氧戊环 5-氧杂-10-氮杂三环[5.3.1.03,8]十一碳-1(10),2,6,8-四烯 3-氧杂二环[3.3.1]壬-6-烯-9-酮 3,4,5,6-四氢-2,7-苯并二氧杂环癸烷e-1,8-二酮 10-(乙酰氧基)-4,5,6,7-四氢-2H-1-苯并氧杂环辛三烯-2,8(3H)-二酮 1-(2,3,4,5-四氢-1,6-苯并二噁辛英-8-基)丙烷-1-酮 1,2-环己烷二甲酸1-甲基-1,2-乙二基酯 (S)-5-烯丙基-2-氧杂双环[3.3.0]辛-8-烯 (7Z)-2-(3-溴丙-1,2-二烯基)-5-(1-溴丙基)-3,3a,5,6,9,9a-六氢-2H-呋喃并[3,2-b]氧杂环辛三烯 (7E)-4,7-二羟基-10-甲基-3,4,5,6,9,10-六氢氧杂环辛三烯-2-酮 (6Z)-10-甲基-3,4,5,8,9,10-六氢-2H-氧杂环辛三烯-2-酮 (5Z,8S)-3-氯-2-[(E)-戊-2-烯-4-炔基]-8-[(E)-丙-1-烯基]-3,4,7,8-四氢-2H-氧杂环辛三烯 (4Z)-3,6-二氢-2,7-苯并二氧杂环癸烷e-1,8-二酮 (4S,5Z,7S,8S,10R)-4,7,8-三羟基-10-甲基-3,4,7,8,9,10-六氢氧杂环辛三烯-2-酮 (4R,5R,6Z,8S,10R)-4,5,8-三羟基-10-甲基-3,4,5,8,9,10-六氢氧杂环辛三烯-2-酮 (2R,5Z)-8a-[(R)-1-溴丙基]-3a-氯-3,4,7,8-四氢-2a-[(Z)-2-戊烯-4-炔基]-2H-氧杂环辛三烯 1,3,3a,6a-tetrahydro-5-pentyl-4H-cyclopentafuran-4-one trans-1-oxacyclodec-7-ene-2-one 2-epi-herbarumin II (RS)-5-methoxy-2,3,5,6-tetrahydro-8H-benzo[1,4,7]trioxecin β-heptenolactone stagonolide-E fumaric acid butanediyl ester aspinolide A (3R,4R,9S,10R,Z)-4,9-dihydroxy-3-methyl-10-pentyl-3,4,7,8,9,10-hexahydro-2H-oxecin-2-one prelaureatin 8-acetyl-4,4-dimethyl-2,6-dioxo-9-(2-methylpropyl)-2,3,4,5,6,8-hexahydrooxocino[2,3-c]pyrrole 5,6-benzo-2,3-diethoxy-4-oxo-2-hepten-7-olide 3,4,5,6-tetrahydro-oxocin-2-one (Z)-3-butyl-5,6,7,8-tetrahydro-2H-oxocin-2-one presaccharothriolide X 1-{2-[4,5-dihydro-1H-2-benzoxocin-(6Z)-ylidenemethyl]-allyl}-piperidine (R,Z)-8-(methoxymethoxy)-2,2,6,9-tetramethyl-5,6-dihydro-2H-benzo[b]oxocine 5-hydroxy-7R,11-heliannan-10-one 8-methoxy-2,2,6,9-tetramethyl-2H-1-benzoxocin-3(4H)-one 8-methoxy-2,2,6,9-tetramethyl-3,4,5,6-tetrahydro-2H-1-benzoxocin-3-ol (4S,5Z,10R)-4-hydroxy-10-methyl-3,4,7,8,9,10-hexahydro-2H-oxecin-2-one (4R)-9,11-bis(benzyloxy)-4-methyl-4,5,6,7-tetrahydro-1H-benzo[d]-oxecine-2,8-dione ethyl (4Z)-4-methyl-7,8-dihydro-1,3,6-trioxocine-5-carboxylate 4-hydroxy-10-(2-hydroxyethyl)-1,2-dihydro-4,12a-methanooxocino[4,5-b][1,4]benzodioxin-5-one 4-hydroxy-9-(2-hydroxyethyl)-1,2-dihydro-4,12a-methanooxocino[4,5-b][1,4]benzodioxin-5-one (7R,9R,5E)-7-hydroxy-9-propylnon-5-en-9-olide (6S,7R,9R)-6,7-dihydroxy-9-propylnon-4-eno-9-lactone 7-[2-(3,5-Dichloro-N-oxo-pyridin-4-yl)-1-oxoethyl]-10-methoxy-2,3,4,5-tetrahydro-1,6-benzodioxocine